The use of (18F)fluoro-deoxyglucose positron emission tomography in the assessment of large vessel vasculitis

被引：0
|
作者：
Blockmans, D [1 ]
机构：
[1] Univ Hosp Gasthuisberg, Dept Gen Internal Med, B-3000 Louvain, Belgium
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2003年 / 21卷 / 06期
关键词：
Aortitis; FDG-PET scintigraphy; giant-cell arteritis; Takayasu arteritis; periaortitis; multifocal fibrosclerosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FDG-PET scan has recently been introduced as a diagnostic means to assess large vessel involvement in giant cell arteritis (GCA). Its use in Takayasu arteritis, idiopathic periaortitis and multifocal fibrosclerosis - although more limited, due to the relative rarity of these conditions. compared to GCA is discussed as well.
引用
收藏
页码：S15 / S22
页数：8
相关论文
共 50 条
  • [1] (18F) fluoro-deoxyglucose positron emission tomography in patients with fever of unknown origin
    Blockmans, D
    [J]. ACTA CLINICA BELGICA, 2004, 59 (03): : 134 - 137
  • [2] Clinical value of [18F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin
    Blockmans, D
    Knockaert, D
    Maes, A
    De Caestecker, J
    Stroobants, S
    Bobbaers, H
    Mortelmans, L
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (02) : 191 - 196
  • [3] Vasculitis assessment with [18F]FDG positron emission tomography
    Liozon, E.
    Monteil, J.
    Ly, K. H.
    Vidal, E.
    [J]. REVUE DE MEDECINE INTERNE, 2010, 31 (06): : 417 - 427
  • [4] Vasculitis assessment with [18F]FDG positron emission tomography
    Liozon, E.
    Monteil, J.
    [J]. MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2008, 32 (10): : 511 - 522
  • [5] Diagnosis of Large-Vessel Vasculitis by [18F] Fluorodeoxyglucose-Positron Emission Tomography
    Neumann, Thomas
    Oelzner, Peter
    Freesmeyer, Martin
    Hansch, Andreas
    Opfermann, Thomas
    Hein, Gert
    Wolf, Gunter
    [J]. CIRCULATION, 2009, 119 (02) : 338 - 339
  • [6] Value of (18)fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma
    Bender, H
    Kirst, J
    Palmedo, H
    Schomburg, A
    Wagner, U
    Ruhlmann, J
    Biersack, HJ
    [J]. ANTICANCER RESEARCH, 1997, 17 (3B) : 1687 - 1692
  • [7] Evaluation of efficacy and clinical impact of positron emission tomography with 18f fluoro-deoxyglucose (FDG) in patients with suspicion of recurrent laryngeal carcinoma
    Alvarez Perez, R. M.
    Borrego Dorado, I.
    Vazquez Albertino, R.
    Ruiz Franco-Baux, J.
    Ceballo Pedraja, J. M.
    Esteban Ortega, F.
    [J]. ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2006, 57 (03): : 134 - 139
  • [8] Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease
    Albin, RL
    Minoshima, S
    DAmato, CJ
    Frey, KA
    Kuhl, DA
    Sima, AAF
    [J]. NEUROLOGY, 1996, 47 (02) : 462 - 466
  • [9] Utility of [18F] Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography for Staging and Therapy Response Evaluation in Pediatric Rhabdomyosarcoma: A Case Series and Literature Review
    Sa, Ri
    Liu, Danyan
    Zhao, Hongguang
    Hou, Sen
    Lin, Qiuyu
    Guan, Feng
    [J]. FRONTIERS IN MEDICINE, 2020, 7
  • [10] Repeatability of [18F] fluoro-deoxyglucose positron emission tomography (FDG-PET) in a multicenter phase I oncology study in patients with gastrointestinal malignancies
    Velasquez, L. M.
    Kollia, G.
    Hayes, W.
    Galbraith, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345